[ARS] BRISTOL MYERS SQUIBB CO SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

03/25/2026 - 05:16 PM

ARS - BRISTOL MYERS SQUIBB CO

ARS Filing - BRISTOL MYERS SQUIBB CO

This filing is available as a PDF document.

Filing Type: ARS

Company: BRISTOL MYERS SQUIBB CO (BMY)

Acceptance Date: 2026-03-25T17:16:58.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Bristol-Myers Squibb Co

NYSE:BMY

View BMY Stock Overview →

BMY Rankings

#124 Ranked by Market Cap

#621 Ranked by Dividends

#1144 52-Week Gainer

#502 YTD Gainer

#1010 Monthly Gainer

#730 Ranked by Short %Change

BMY Latest News

Mar 23, 2026

Three New Studies Show Viz.ai’s Cardio Suite Speeds Detection of Cardiac Disease and Improves Patient Follow-Up

Mar 23, 2026

insitro and Bristol Myers Squibb Collaboration Expanded with Nomination of New Targets

Mar 23, 2026

Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology Annual Scientific Session & Expo 2026 (ACC.26)

Mar 20, 2026

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)

Mar 19, 2026

Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026

BMY Latest SEC Filings

Mar 26, 2026

[SCHEDULE 13G/A] BRISTOL MYERS SQUIBB CO Amended Passive Investment Disclosure

Mar 25, 2026

[DEF 14A] BRISTOL MYERS SQUIBB CO Definitive Proxy Statement

Mar 12, 2026

[Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity

Mar 12, 2026

[Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity

Mar 12, 2026

[Form 4] BRISTOL MYERS SQUIBB CO Insider Trading Activity

BMY Stock Data

Market Cap 116.87B

Float 2.03B

Industry Drug Manufacturers - General

Sector Pharmaceutical Preparations

Website Link

Country United States

City PRINCETON